4Anderson H,Hopwood P,Stephens RJ,et al.Gemcitabine plus best supportive care(BSC)vs BSC in inoperable non-small cell lung cancer-a randomized trial with quality of life as the primary outcome.UK NSCLC Gemcitabine Group.Non-Small Cell Lung Cancer[J].Br J Cancer,2000,83(4):447-453.
5[No authors listed]Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer.The Elderly Lung Cancer Vinorelbine Italian Study Group[J].J Natl Cancer Inst,1999,91(1):66-72.
6Shepherd FA,Dancey J,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy[J].J Clin Oncol,2000,18(10):2095-2103.
7Ranson M,Davidson N,Nicolson M,et al.Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer[J].J Natl Cancer Inst,2000,92(13):1074-1080.
10Roth JA,Nguyen DM,Kemp BL,et al.Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer[J].Nature Medicine,1996,2:985-991.
